uce
ProgressImage ProgressImage
Glenmark Pharmaceuticals Ltd
Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code 532296 border-img ISIN Demat INE935A01035 border-img Book Value 651.23 border-img NSE Symbol GLENMARK border-img Div & Yield % 0.24 border-img Market Cap ( Cr.) 29742.63 border-img P/E 28.26 border-img EPS 37.29 border-img Face Value 1
Quarters
ParticularsDec 2023
()
Sep 2023
()
Jun 2023
()
Gross Sales1304.162170.402098.06
Other Operating Income60.9363.0146.32
Other Income 258.8273.5849.36
Total Income1623.912306.992193.75
Total Expenditure 1574.651809.601691.02
PBIDT49.26497.40502.73
Interest 73.6058.1961.93
PBDT-24.34439.21440.79
Depreciation51.1649.8548.75
Tax-53.179.2238.57
Fringe Benefit Tax0.000.000.00
Deferred Tax-1.9377.8081.82
Reported Profit After Tax-20.41302.35271.66
Extra-ordinary Items -25.28-15.27-21.92
Adjusted Profit After Extra-ordinary item4.87317.62293.58
    
EPS (Unit Curr.)-0.7210.729.63
EPS (Adj) (Unit Curr.)-0.7210.729.63
Calculated EPS (Unit Curr.)-0.7210.729.63
Calculated EPS (Adj) (Unit Curr.)-0.7210.729.63
Calculated EPS (Ann.) (Unit Curr.)-2.8942.8638.51
Calculated EPS (Adj) (Ann.) (Unit Curr.)-2.8942.8638.51
Book Value (Unit Curr.)0.000.000.00
Dividend (%)0.000.000.00
Equity28.2228.2228.22
Reserve & Surplus0.000.000.00
Face Value1.001.001.00
    
Public Shareholding (No. Of Shares)0.000.000.00
Public Shareholding (% in Equity)0.000.000.00
    
Pledged/Encumbered - No. of Shares0.000.000.00
Pledged/Encumbered - % in Total Promoters Holding0.000.000.00
Pledged/Encumbered - % in Total Equity0.000.000.00
    
Non Encumbered - No. of Shares0.000.000.00
Non Encumbered - % in Total Promoters Holding0.000.000.00
Non Encumbered - % in Total Equity0.000.000.00
    
PBIDTM(%)3.7822.9223.96
PBDTM(%)-1.8720.2421.01
PATM(%)-1.5613.9312.95
x
x
×
Let's Chat
close
refresh